News
11h
Zacks Investment Research on MSNBoston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to NoteBoston Scientific (BSX) closed the latest trading day at $93.67, indicating a +1.11% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 1.81%. At ...
1d
Zacks Investment Research on MSNBoston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains?Boston Scientific BSX shares rallied 6.8% in the last trading session to close at $96.77. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
including Boston Scientific (NYSE:BSX), Stryker (NYSE:SYK), and Medtronic (NYSE:MDT). Tariffs will impact medical devices depending on where the products are manufactured. While the U.S. remains a ...
Boston Scientific (BSX) closed the latest trading ... The average PEG ratio for the Medical - Products industry stood at 2.09 at the close of the market yesterday.
A diversified portfolio, strategic acquisitions, and aggressive R&D have driven Boston Scientific's recent ... and interacts with the company’s products and representatives.
ATLANTA, July 6 /PRNewswire-FirstCall/ -- Corautus Genetics Inc. (NASDAQ:VEGF), a clinical stage biopharmaceutical company dedicated to the development of new and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results